Streetbeat News

Analyst Ratings

NAMS

Piper Sandler has reiterated its Overweight rating on NewAmsterdam Pharma (NASDAQ:NAMS) and maintained a price target of $37.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:30 pm

MSFT

DA Davidson has downgraded Microsoft from Buy to Neutral, setting a price target of $475.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:30 pm

CORZ

Canaccord Genuity has initiated coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and set a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:26 pm

KVUE

Piper Sandler has maintained a Neutral rating on Kenvue (NYSE:KVUE) while raising the price target from $20 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:26 pm

PEG

Morgan Stanley analyst David Arcaro has maintained an Overweight rating on Public Service Enterprise (NYSE:PEG) and raised the price target from $83 to $95.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:25 pm

MLTX

Cantor Fitzgerald analyst Prakhar Agrawal has reiterated an Overweight rating on MoonLake (NASDAQ:MLTX).

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:23 pm

GM

Bernstein analyst Daniel Roeska has downgraded General Motors (NYSE:GM) from Outperform to Market Perform, setting a price target of $53. This update corrects the analyst's name from a previous publication.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:23 pm

AJG

DRI

FERG

LUNR

MU

Wall Street analysts with high accuracy rates have made recent stock picks, including Micron Technology, which is expected to see a 92% upside. The Federal Reserve cut interest rates, boosting major indices. Benzinga's Analyst Ratings API provides insights into top analyst picks.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 12:17 pm

EA

Benchmark analyst Mike Hickey has reiterated a Buy rating on Electronic Arts (NASDAQ:EA) and maintained a price target of $163.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:16 pm

VST

Morgan Stanley analyst Stephen Byrd maintains an Overweight rating on Vistra (NYSE:VST) and raises the price target from $110 to $132.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:13 pm